Medical device

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CareDx, Spero, LMP, and Dentsply Sirona and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, June 30, 2022 - 2:00am

Throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment.

Key Points: 
  • Throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment.
  • In order to facilitate this scheme, Dentsply and its executives made numerous false and misleading statements to investors during the Class Period.
  • For more information on the Dentsply Sirona class action go to: https://bespc.com/cases/XRAY
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Is Investigating Inotiv, TG Therapeutics, Allianz, and Outset Medical and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, June 30, 2022 - 2:00am

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • The complaint is a civil action by DOJ alleging violations of the Animal Welfare Act at the Cumberland, Virginia facility.
  • For more information on the Outset Medical investigation go to: https://bespc.com/cases/OM
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Great Panther Announces Agreement to Sell the Guanajuato Mine Complex and Topia Mine in Mexico

Retrieved on: 
Wednesday, June 29, 2022 - 11:38pm

"Furthermore, GSilver's processing and tailings facilities in the district provide the platform for a near-term re-start of operations at the GMC.

Key Points: 
  • "Furthermore, GSilver's processing and tailings facilities in the district provide the platform for a near-term re-start of operations at the GMC.
  • Our capital allocation priorities are focused on Tucano as this is where we see the greatest value creation potential for our stakeholders.
  • Great Panther has engaged GenCap Mining Advisory Ltd. as its sole financial advisor and McCarthy Ttrault LLP and RB Mexico Law-Abogados as its legal advisors in connection with the Agreement.
  • Great Panther trades on the Toronto Stock Exchange trading under the symbol GPR and on the NYSE American under the symbol GPL.

Northwest Extremity Specialists and Unity MSK Partner with Tigard Orthopedic and Fracture Clinic

Retrieved on: 
Wednesday, June 29, 2022 - 11:37pm

PORTLAND, Ore., June 29, 2022 /PRNewswire/ -- The Tigard Orthopedic and Fracture Clinic (TOFC), led by Dr. Ronald Bowman, has partnered with Unity MSK and is now part of the Northwest Extremity Specialists (NES) group in Portland, OR.

Key Points: 
  • PORTLAND, Ore., June 29, 2022 /PRNewswire/ -- The Tigard Orthopedic and Fracture Clinic (TOFC), led by Dr. Ronald Bowman, has partnered with Unity MSK and is now part of the Northwest Extremity Specialists (NES) group in Portland, OR.
  • Unity MSK, which also partners with a large orthopedic practice, Los Angeles Orthopedic Surgery Specialists, in Los Angeles, is a management services company providing support to orthopedic and podiatry practices across the United States.
  • Northwest Extremity Specialists is the largest podiatry practice in Oregon and the addition of Tigard Orthopedics and Fracture Clinic represents an initial expansion into the orthopedic specialty area.
  • "We are excited to partner with both Northwest Extremity Specialists and Unity MSK to expand our orthopedic practice here in Portland; all to the benefit of the patients and communities we serve.

UL Solutions Acquires Data Test Labs

Retrieved on: 
Wednesday, June 29, 2022 - 11:23pm

NORTHBROOK, Ill., June 29, 2022 /PRNewswire/ -- UL Solutions, a global leader in applied safety science, today announced its acquisition of Data Test Labs, a Michigan-based company focusing on electrical, environmental and mechanical testing for automakers and their suppliers.

Key Points: 
  • NORTHBROOK, Ill., June 29, 2022 /PRNewswire/ -- UL Solutions, a global leader in applied safety science, today announced its acquisition of Data Test Labs, a Michigan-based company focusing on electrical, environmental and mechanical testing for automakers and their suppliers.
  • "We founded Data Test Labs on the tenet that validation testing helps to assure a product's quality and reliability and is critically important for interconnected safety-critical vehicle systems," said Janssen.
  • A global leader in applied safety science, UL Solutions transforms safety, security and sustainability challenges into opportunities for customers in more than 100 countries.
  • UL Solutions delivers testing, inspection and certification services, together with software products and advisory offerings, that support our customers' product innovation and business growth.

The LGMD Community Celebrates Adoption of ICD-10 Diagnostic Codes for LGMD

Retrieved on: 
Wednesday, June 29, 2022 - 10:52pm

The implementation of these ICD-10 codes represents a culmination of two-years of collaborative efforts within the LGMD patient, clinical, and research communities.

Key Points: 
  • The implementation of these ICD-10 codes represents a culmination of two-years of collaborative efforts within the LGMD patient, clinical, and research communities.
  • These diagnostic codes will be fully implemented and ready for use starting this October.
  • This significant advance could well shorten the diagnostic odyssey for individuals with LGMD, facilitate the targeted care the community needs, and accelerate surveillance and epidemiological research.
  • This milestone is the culmination of over two years of collaborative efforts between LGMD advocacy organizations and leading LGMD clinicians and researchers.

The Worldwide Terrestrial Trunked Radio (TETRA) Industry is Projected to Reach $9.6 Billion by 2027

Retrieved on: 
Wednesday, June 29, 2022 - 9:00pm

The Global Terrestrial Trunked Radio (TETRA) Market is estimated to be USD 4.37 Bn in 2022 and is projected to reach USD 9.6 Bn by 2027, growing at a CAGR of 17.04%.

Key Points: 
  • The Global Terrestrial Trunked Radio (TETRA) Market is estimated to be USD 4.37 Bn in 2022 and is projected to reach USD 9.6 Bn by 2027, growing at a CAGR of 17.04%.
  • Market dynamics are forces that impact the prices and behaviors of the Global Terrestrial Trunked Radio (TETRA) Market stakeholders.
  • The report presents a detailed Ansoff matrix analysis for the Global Terrestrial Trunked Radio (TETRA) Market.
  • The report offers a comprehensive evaluation of the Global Terrestrial Trunked Radio (TETRA) Market.

National Safety Council to Release New Report: Mobility, Technology and Safety: The Next 20 Years

Retrieved on: 
Wednesday, June 29, 2022 - 9:00pm

WASHINGTON, June 29, 2022 /PRNewswire/ -- The National Safety Council released Wednesday the executive summary of its new research report, Mobility, Technology and Safety: The Next 20 Years. The full report, funded by Allstate (NYSE: ALL) and to be released July 26 via a webinar, explores the evolution of mobility and the implications of past actions on the future of safe mobility.

Key Points: 
  • Vulnerable road users, those who are walking, biking or are otherwise outside a vehicle, are dying at faster rates.
  • Communities of color and low-income communities also experience higher rates of fatalities and are over-represented in these data.
  • The report, Mobility, Technology and Safety: The Next 20 Years,is intended to supplement and add momentum to these ongoing federal efforts, providing much needed solutions for communities grappling with real safety problems.
  • The National Safety Council is America's leading nonprofit safety advocateand has been for more than 100 years.

PetVivo to Discuss Financial Results for the Fiscal Year End ended March 31, 2022 and Business Update

Retrieved on: 
Wednesday, June 29, 2022 - 9:00pm

EDINA, MN, June 29, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for its fiscal year ended March 31, 2022.

Key Points: 
  • Fiscal Year Ended March 31, 2022 (fiscal 2022) Compared to The Year Ended March 31, 2021 (fiscal 2021)
    Total Revenues.
  • Revenues increased to $115,586 in fiscal 2022 compared to $12,578 in fiscal 2021 and consisted of sales to veterinary clinics.
  • Cost of sales was $201,154 in fiscal 2022 compared to $10,695 for fiscal 2021.
  • Operating expenses increased to $4,970,960 in fiscal 2022 compared to $1,960,871 in fiscal 2021.

85% of U.S. CEOs could be leaving their businesses open to reputational and financial risks by releasing insufficiently tested software

Retrieved on: 
Wednesday, June 29, 2022 - 8:30pm

LONDON, June 29, 2022 /PRNewswire-PRWeb/ -- According to new research by no-code software test automation platform company, Leapwork, 85% of U.S. CEOs think it's acceptable to release software that hasn't been properly tested, so long as it's patch tested later. And 79% of testers say that up to 40% of software goes to market without sufficient testing. As a result, 52% of testers claim their teams spend five to 10 days per year patching software.

Key Points: 
  • Despite the majority of testers expressing concern that insufficiently tested software is going to market, the overwhelming majority of CEOs (94%) say they're confident their software is tested regularly.
  • CEOs are aware of the risks of insufficient testing, with 95% of CEOs saying they are concerned about losing their jobs in the wake of a software failure.
  • In addition, both CEOs and testers see risks to their companies due to insufficiently tested software.
  • More than three-quarters of CEOs (77%) say software failures have harmed their company's reputation in the last five years.